HEPION PHARMACEUTICALS, INC. Severance Costs
HEPION PHARMACEUTICALS, INC. (HEPA) reported Severance Costs of $1.30 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SeveranceCosts1 · last filed 2019-03-14
- HEPION PHARMACEUTICALS, INC. severance costs for fiscal 2018 was $1.30M.
| Period end | Severance Costs 1 month | Severance Costs 12 month |
|---|---|---|
| 2018-12-31 | $1.30M 10-K · filed 2019-03-14 | |
| 2018-10-31 | $0.00 10-Q · filed 2018-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |